Fieldpoint Private Securities’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-22
| Closed | -$2K | – | 1763 |
|
|
2022
Q1 | $2K | Sell |
22
-127
| -85% | -$11.5K | ﹤0.01% | 1522 |
|
|
2021
Q4 | $17K | Sell |
149
-93
| -38% | -$10.6K | ﹤0.01% | 926 |
|
|
2021
Q3 | $30K | Hold |
242
| – | – | 0.01% | 707 |
|
|
2021
Q2 | $31K | Sell |
242
-8
| -3% | -$1.03K | 0.01% | 680 |
|
|
2021
Q1 | $34K | Sell |
250
-14,194
| -98% | -$1.93M | 0.01% | 652 |
|
|
2020
Q4 | $2.03M | Buy |
14,444
+315
| +2% | +$44.3K | 0.46% | 58 |
|
|
2020
Q3 | $1.57M | Buy |
14,129
+1,564
| +12% | +$174K | 0.46% | 61 |
|
|
2020
Q2 | $1.41M | Buy |
12,565
+6,666
| +113% | +$746K | 0.47% | 60 |
|
|
2020
Q1 | $457K | Buy |
5,899
+1,324
| +29% | +$103K | 0.18% | 143 |
|
|
2019
Q4 | $435K | Buy |
4,575
+315
| +7% | +$30K | 0.13% | 168 |
|
|
2019
Q3 | $325K | Sell |
4,260
-400
| -9% | -$30.5K | 0.12% | 176 |
|
|
2019
Q2 | $409K | Hold |
4,660
| – | – | 0.13% | 165 |
|
|
2019
Q1 | $422K | Hold |
4,660
| – | – | 0.17% | 138 |
|
|
2018
Q4 | $334K | Sell |
4,660
-125
| -3% | -$8.96K | 0.15% | 152 |
|
|
2018
Q3 | $459K | Hold |
4,785
| – | – | 0.17% | 135 |
|
|
2018
Q2 | $455K | Hold |
4,785
| – | – | 0.17% | 132 |
|
|
2018
Q1 | $420K | Sell |
4,785
-1,077
| -18% | -$94.5K | 0.19% | 115 |
|
|
2017
Q4 | $498K | Hold |
5,862
| – | – | 0.26% | 98 |
|
|
2017
Q3 | $507K | Buy |
5,862
+977
| +20% | +$84.5K | 0.22% | 114 |
|
|
2017
Q2 | $377K | Hold |
4,885
| – | – | 0.26% | 53 |
|
|
2017
Q1 | $339K | Buy |
+4,885
| New | +$339K | 0.26% | 79 |
|